Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys

Journal of Infectious Diseases

Volumn 191, Issue 6, 2005, Pages 1000-1004

  Kochel, Tadeusz J ^a,c   Watts, Douglas M ^a,d   Gozalo, Alfonso S ^a,e   Ewing, Daniel F ^b   Porter, Kevin R ^b,c   Russell, Kevin L ^a,f  

^a California   (Peru)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL MODEL; ANTIBODY TITER; AOTUS; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; FEMALE; GENOTYPE; MALE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VIREMIA; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; AOTIDAE; CROSS REACTIONS; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; MALE; NEUTRALIZATION TESTS; SEROTYPING; VIREMIA;

EID: 14844290217     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/427511     Document Type: Article

References (16)

1. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239:476-81.
2. Gubler DJ. The arboviruses: epidemiology and ecology. Vol. 2. Boca Raton: CRC Press, 1992:223-60.
3. Halstead SB. Observations related to pathogenesis of dengue hemorrhagic fever. Vl. Hypotheses and discussion. Yale J Biol Med 1970; 42: 350-62.
4. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988; 38:411-9.
5. Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg 1952; 1:30-50.
6. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38:172-80.
7. Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 1990; 42:179-84.
8. Thein S, Aung MM, Shwe TN, et al. Risk factors in dengue shock syndrome. Am J Trop Med Hyg 1997; 56:566-72.
9. Watts DM, Porter R, Putvatana P, et al. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 1999; 354:1431-4.
10. Institute for Laboratory Animal Research, National Research Council. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press, 1996.
11. Kochel TJ, Watts DM, Halstead SB, et al. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 2002; 360:310-2.
12. Henchal EA, Gentry MK, McCown JM, Brandt WE. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg 1982; 31:830-6.
13. Rico-Hesse R, Harrison LM, Salas RA, et al. Origins of dengue type 2 viruses associated with increased pathogenidty in the Americas. Virology 1997; 230:244-51.
14. Armstrong PM, Rico-Hesse R. Differential susceptibility of Aedes aegypti to infection by the American and southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis 2001; 1:159-68.
15. Cologna R, Rico-Hesse R. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol 2003; 77:3929-38.
16. Pryor MJ, Carr JM, Hocking H, Davidson AD, Li P, Wright PJ. Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. Am J Trop Med Hyg 2001; 65:427-34.